This story first ran in the College Issue of TheWrap magazine. The post The Top 50 Film Schools of 2025 appeared first on ...
Highlights† Reported revenue of $384.2 million, up 13.0%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, ...
ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a ...
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...
CaterCow reports that 53% of employees prefer catered lunches over holiday parties, emphasizing food's role in workplace ...
MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...
Q3 2025 Earnings Call Transcript October 29, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...
Florida Supplement Brand Expands ‘Gelatin Trick’ Coverage With Clinically Referenced Morning, Afternoon, and Evening Recipes Supporting Healthy Metabolism ...
Prediction markets are having a moment. In this episode of Motley Fool Money, analysts Emily Flippen and Sanmeet Deo and ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
The Christian Post on MSNOpinion
A new kind of 'Roe Effect' has appeared
A new reality that has emerged is global in scope: a worldwide collapse in birth rates that has affected nations irrespective ...
1. About lecanemab (generic name, brand name: LEQEMBI®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback